Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Lymphoma 15Breast Neoplasms 13Leukemia, Myeloid, Acute 11Carcinoma, Non-Small-Cell Lung 11Glioblastoma 10Lymphoma, Non-Hodgkin 8Lymphoma, Large B-Cell, Diffuse 8Lymphoma, Follicular 8Brain Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Mantle-Cell 7Leukemia 7Multiple Myeloma 6Hodgkin Disease 6Neoplasms 5Myelodysplastic Syndromes 5Lymphoma, T-Cell, Cutaneous 5Lung Neoplasms 5Gliosarcoma 5Congenital Abnormalities 5Breast Neoplasms, Male 5Recurrence 4Lymphoma, Large-Cell, Anaplastic 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myelomonocytic, Acute 4Leukemia, Monocytic, Acute 4Leukemia, Megakaryoblastic, Acute 4Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia, Erythroblastic, Acute 4Immunoblastic Lymphadenopathy 4

Interventions

Doxorubicin 6pazopanib 5Gemcitabine 4pembrolizumab 3Trabectedin 3Sorafenib 3Docetaxel 3Dacarbazine 3eribulin 2Sunitinib 2Radiotherapy, Conformal 2Radiotherapy 2Nivolumab 2Letrozole 2Ifosfamide 2Bevacizumab 2tremelimumab 1temsirolimus 1saracatinib 1sapanisertib 1rucaparib 1romidepsin 1olaratumab 1mocetinostat 1liposomal doxorubicin 1lenvatinib 1indolepropanol phosphate 1durvalumab 1cixutumumab 1cabozantinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leiomyosarcoma × Vorinostat × Clear all
NCT03509207 2020-08-04

Vorinostat (SAHA) in Uterine Sarcoma

Medical University of Graz

Phase 2 Terminated
3 enrolled 6 charts
GynecologicSarcoma

Leiomyosarcoma, Endometrial Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡